Skip to main content

Table 3 Comparison of patents’ survival events in two datasets

From: Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico

Survival events

n

Cases (%)

χ2

P value

GSE49997

GSE9891

OS event

0.83

> 0.05

 Alive

312

137 (70.6%)

190 (66.7%)

  

 Dead

167

57 (29.4%)

95 (33.3%)

  

PFS event

0.15

> 0.05

 Non-progressive

162

70 (36.1%)

98 (34.4%)

  

 Progressive

317

124 (63.9%)

187 (65.6%)

  
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us